β-Carboline and chloroquine hybrids as potent antiplasmodial agents: Design, synthesis and biological evaluation

Ana Penava; Lais Pessanha De Carvalho; Jana Held; Goran Poje; Zrinka Rajić; Ivana Perković

doi:10.2478/acph-2026-0016

.blurhash-client-img { display: none !important; }

β-Carboline and chloroquine hybrids as potent antiplasmodial agents: Design, synthesis and biological evaluation

Acta Pharmaceutica

Volume 76 (2026): Issue 2 (June 2026)

By: Ana Penava , Lais Pessanha De Carvalho , Jana Held , Goran Poje , Zrinka Rajić and Ivana Perković

Open Access

|Jun 2026

Abstract

A series of thirteen novel β-carboline and chloroquine (CQ) hybrids was designed and synthesized. The compounds were evaluated for in vitro antiplasmodial activity against Plasmodium falciparum strains 3D7 (CQ-sensitive) and Dd2 (multidrug-resistant). All compounds exhibited potent activity, with IC₅₀ values in the nanomolar to low micromolar range, while retaining potency against the resistant strain (1.0 to 365.5 nmol L^–1 for 3D7 and from 2.2 to 2415.3 nmol L^–1 for Dd2 strain). Several compounds were more active against Dd2, then against 3D7 strain with resistance index (RI) lower than 1. Moreover, nearly all compounds showed lower RI values compared to CQ which additionally underscores their outstanding activity. At the highest tested concentration (250 μmol L^–1), no cytotoxicity was observed in HepG2 cells, resulting in favourable selectivity indices expressed as lower limits. Overall, the obtained results confirm strong antiplasmodial activity of the β-carboline and chloroquine hybrids as promising antiplasmodial candidates, particularly due to their activity against resistant strains and improved selectivity.

References

S. Kumar, T. R. Bhardwaj, D. N. Prasad and R. K. Singh, Drug targets for resistant malaria: Historic to future perspectives, Biomed. Pharmacother. 104 (2018) 8–27; https://doi.org/10.1016/j.biopha.2018.05.009
Search in Google Scholar Back to article
J. L. Siqueira-Neto, K. J. Wicht, K. Chibale, J. N. Burrows, D. A. Fidock and E. A. Winzeler, Anti-malarial drug discovery: Progress and approaches, Nat. Rev. Drug Discov. 22(10) (2023) 807–826; https://doi.org/10.1038/s41573-023-00772-9
Search in Google Scholar Back to article
World Health Organization. World malaria report 2025. Geneva: World Health Organization; 2025; https://www.who.int/publications/i/item/world-malaria-report-2025; last access date March 15, 2026.
Search in Google Scholar Back to article
MMV’s pipeline of antimalarial drugs; https://www.mmv.org/mmv-pipeline-antimalarial-drugs; last access date March 15, 2026
Search in Google Scholar Back to article
H. Li, S. Ji, N. R. Ariefta, E. M. S. Galon, S. A. E. S. El-Sayed, T. Do, L. Jia, M. Sakaguchi, M. Asada, Y. Nishikawa, X. Qin, M. Liu and X. Xuan, Efficacy and mechanism of action of cipargamin as an antibabesial drug candidate, eLife 13 (2025) Article ID RP101128 (17 pages); https://doi.org/10.7554/eLife.101128
Search in Google Scholar Back to article
D. G. Okwu, R. Z. Manego, S. Duparc, P. G. Kremsner, M. Ramharter and G. Mombo-Ngoma, The non-artemisinin antimalarial drugs under development: A review, Clin. Microbiol. Infect. 31(6) (2025) 941–947; https://doi.org/10.1016/j.cmi.2025.03.009
Search in Google Scholar Back to article
B. K. S. Yeung, KAE609 (Cipargamin): Discovery of spiroindolone antimalarials, Novartis Institute for Tropical Diseases, Singapore.
Search in Google Scholar Back to article
M. Lenharo, First new type of malaria treatment in decades shows promise against drug resistance, Nature 647(8091) (2025) Article ID 830 (1 page); https://doi.org/10.1038/d41586-025-03690-5
Search in Google Scholar Back to article
G. M. LaMonte, F. Rocamora, D. S. Marapana, N. F. Gnädig, S. Ottilie, M. R. Luth, T. S. Worgall, G. M. Goldgof, R. Mohunlal, T. R. Santha Kumar, J. K. Thompson, E. Vigil, J. Yang, D. Hutson, T. Johnson, J. Huang, R. M. Williams, B. Y. Zou, A. L. Cheung, P. Kumar, T. J. Egan, M. C. S. Lee, D. Siegel, A. F. Cowman, D. A. Fidock and E. A. Winzeler, Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway, Nat. Commun. 11(1) (2020) Article ID 1780 (15 pages); https://doi.org/10.1038/s41467-020-15440-4
Search in Google Scholar Back to article
T. Umumararungu, J. B. Nkuranga, G. Habarurema, J. B. Nyandwi, M. J. Mukazayire, J. Mukiza, R. Muganga, I. Hahirwa, M. Mpenda, A. N. Katembezi, E. O. Olawode, E. Kayitare and P. C. Kayumba, Recent developments in antimalarial drug discovery, Bioorg. Med. Chem. 88–89 (2023) Article ID 117339 (21 pages); https://doi.org/10.1016/j.bmc.2023.117339
Search in Google Scholar Back to article
S. Tahlan, S. Singh, M. Kaira, H. Dey and K. C. Pandey, A progress report in advancements of heterocyclic compounds as novel antimalarial agents over the last 5 years, Eur. J. Med. Chem. 289 (2025) Article ID 117393 (53 pages); https://doi.org/10.1016/j.ejmech.2025.117393
Search in Google Scholar Back to article
N. J. White, Tafenoquine – a new antimalarial drug, Clin. Infect. Dis. 69(10) (2019) 1816–1823; https://doi.org/10.1093/cid/ciz070
Search in Google Scholar Back to article
B. Meunier and A. Robert, Heme as a target for antimalarial drugs, Acc. Chem. Res. 43(1) (2010) 144–150; https://doi.org/10.1021/ar900207e
Search in Google Scholar Back to article
V. Vaishali, V. Kumar, D. Singh, S. Sharma and V. Singh, A deep insight into synthetic and medicinal potential of β-carboline derivatives: An update, ChemistrySelect 10 (2025) e02142 (60 pages); https://doi.org/10.1002/slct.202502142
Search in Google Scholar Back to article
J. Haldar, Combination therapy: A pillar in the fight against infectious diseases, ACS Infect. Dis. 11(12) (2025) 3379–3385; https://doi.org/10.1021/acsinfecdis.5c00932
Search in Google Scholar Back to article
M. L. Stofberg, C. Caillet, M. de Villiers and T. Zininga, Inhibitors of the Plasmodium falciparum Hsp90 towards selective antimalarial drug design: the past, present and future, Cells 10(11) (2021) Article ID 2849 (30 pages); https://doi.org/10.3390/cells10112849
Search in Google Scholar Back to article
A. Penava, M. Marinović, L. P. de Carvalho, J. Held, I. Piantanida, D. P. Saftić, Z. Rajić and I. Perković, Towards novel antiplasmodial agents – design, synthesis and antimalarial activity of second-generation β-carboline/chloroquine hybrids, Molecules 29(24) (2024) Article ID 5991 (30 pages); https://doi.org/10.3390/molecules29245991
Search in Google Scholar Back to article
B. Bálint, C. Wéber, F. Cruzalegui, M. Burbridge and A. Kotschy, Structure-based design and synthesis of harmine derivatives with different selectivity profiles in kinase versus monoamine oxidase inhibition, ChemMedChem 12(12) (2017) 932–939; https://doi.org/10.1002/cmdc.201600539
Search in Google Scholar Back to article
S. Eagon and M. O. Anderson, Microwave-assisted synthesis of tetrahydro-β-carbolines and β-carbolines, Eur. J. Org. Chem. 2014 (2014) 1653–1665; https://doi.org/10.1002/ejoc.201301580
Search in Google Scholar Back to article
G. Poje, L. P. Pessanha de Carvalho, J. Held, D. Moita, M. Prudêncio, I. Perković, T. Tandarić, R. Vianello and Z. Rajić, Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents, Eur. J. Med. Chem. 238 (2022) Article ID 114408 (15 pages); https://doi.org/10.1016/j.ejmech.2022.114408
Search in Google Scholar Back to article
Website for prediction of physicochemical descriptors, ADME parameters, pharmacokinetic properties, druglike nature and medicinal chemistry friendliness of one or multiple small molecules, SwissADME; http://www.swissadme.ch; last access date March 15 2026.
Search in Google Scholar Back to article
L. P. de Carvalho, S. Groeger-Otero, A. Kreidenweiss, P. G. Kremsner, B. Mordmüller and J. Held, Boromycin has rapid-onset antibiotic activity against asexual and sexual blood stages of Plasmodium falciparum, Front. Cell. Infect. Microbiol. 11(1) (2022) Article ID 802294 (13 pages); https://doi.org/10.3389/fcimb.2021.802294
Search in Google Scholar Back to article
H. Noedl, J. Bronnert, K. Yingyuen, B. Attlmayr, H. Kollaritsch and M. Fukuda, Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing, Antimicrob. Agents Chemother. 49(9) (2005) 3575–3577; https://doi.org/10.1128/AAC.49.8.3575-3577.2005
Search in Google Scholar Back to article
R Core Team. A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2021; https://www.r-project.org/; last access date December 21 2021.
Search in Google Scholar Back to article
E. Borenfreund and J. A. Puerner, A simple quantitative procedure using monolayer cultures for cytotoxicity assays (HTD/NR-90), J. Tissue Cult. Methods 9 (1985) 7–9; https://doi.org/10.1007/BF01666038
Search in Google Scholar Back to article
M. V. de Souza, K. C. Pais, C. R. Kaiser, M. A. Peralta, M. de Ferreira and M. C. Lourenço, Synthesis and in vitro antitubercular activity of a series of quinoline derivatives, Bioorg. Med. Chem. 17 (2009) 1474–1480; https://doi.org/10.1016/j.bmc.2009.01.013
Search in Google Scholar Back to article
M. Kitamura, T. Koga, M. Yano and T. Okauchi, Direct synthesis of organic azides from alcohols using 2-azido-1,3-dimethyl-imidazolinium hexafluorophosphate, Synlett. 23 (2012) 1335–1338; https://doi.org/10.1055/s-0031-1290958
Search in Google Scholar Back to article
K. Starčević, D. Pešić, A. Toplak, G. Landek, S. Alihodžić, E. Herreros, S. Ferrer, R. Spaventi and M. Perić, Novel hybrid molecules based on 15-membered azalide as potential antimalarial agents, Eur. J. Med. Chem. 49 (2012) 365–378; https://doi.org/10.1016/j.ejmech.2012.01.039.
Search in Google Scholar Back to article
R. Frederick, C. Bruyere, C. Vancraeynest, J. Reniers, C. Meinguet, L. Pochet, A. Backlund, B. Masereel, R. Kiss and J. Wouters, Novel trisubstituted harmine derivatives with original in vitro anticancer activity, J. Med. Chem. 55 (2012) 6489−6501; https://doi.org/10.1021/jm300542e
Search in Google Scholar Back to article
M. Marinović, G. Poje, I. Perković, D. Fontinha, M. Prudêncio, J. Held, L. P. de Carvalho, T. Tandarić, R. Vianello and Z. Rajić, Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action, Eur. J. Med. Chem. 224 (2021) Article ID 113687 (20 pages); https://doi.org/10.1016/j.ejmech.2021.113687
Search in Google Scholar Back to article
X. Y. Huo, L. Guo, X. F. Chen, Y. T. Zhou, J. Zhang, X. Q. Han and B. Dai, Design, synthesis, and antifungal activity of novel aryl-1,2,3-triazole-β-carboline hybrids, Molecules 23(6) (2018) Article ID 1344 (11 pages); https://doi.org/10.3390/molecules23061344
Search in Google Scholar Back to article
R. Otto, R. Penzis, F. Gaube, T. Winckler, D. Appenroth, C. Fleck, C. Tränkle, J. Lehmann and C. Enzensperger, Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison, Eur. J Med. Chem. 87 (2014) 63–70; https://doi.org/10.1016/j.ejmech.2014.09.048
Search in Google Scholar Back to article
L.-L. Yang, Y.-Y. He, Q.-L. Chen, S. Qian and Z.-Y. Wang, Design and synthesis of new 9-substituted norharmane derivatives as potential Sirt5 inhibitors, J. Heterocyclic Chem. 54 (2017) 1457–1466; https://doi.org/10.1002/jhet.2732
Search in Google Scholar Back to article
A. Daina, O. Michielin and V. Zoete, SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules, Sci. Rep. 7 (2017) Article ID 42717 (13 pages); https://doi.org/10.1038/srep42717
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.2478/acph-2026-0016 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075

Journal RSS Feed

Language: English

Page range: 1 - 26

Accepted on: May 14, 2026

Published on: Jun 30, 2026

Published by: Croatian Pharmaceutical Society

In partnership with: Paradigm Publishing Services

Keywords:

hybrids,

Related subjects:

© 2026 Ana Penava, Lais Pessanha De Carvalho, Jana Held, Goran Poje, Zrinka Rajić, Ivana Perković, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 76 (2026): Issue 2 (June 2026)